The Proatherogenic Role of T Cells Requires Cell Division and Is Dependent on the Stage of the Disease

Objective—The mechanism by which T cells exert a proatherogenic potential is unclear. In order to determine whether this potential requires their replication, we crossed atherosclerosis-prone apolipoprotein E knockout mice (ApoE°) with transgenic mice in which exclusive and conditional ablation of dividing T cells relies on their specific expression of the herpes simplex type 1 thymidine kinase (TK) suicide gene. Methods and Results—We first showed that conalbumin-immunized ApoE°TK mice mounted a significant immune response to the antigen that was fully and specifically blocked by an in vivo ganciclovir (GCV) treatment. Next, ApoE°TK mice and ApoE° mice were treated or not with GCV either during the first 4 weeks (GCV 1 to 4w), the last 4 weeks (GCV 5 to 8w), or during 8 weeks (GCV 1 to 8w). Strikingly, ApoE°TK mice displayed a dramatic decrease in lesion development in the GCV 1 to 8w and GCV 5 to 8w groups, whereas the GCV had no effect when administered during the first 4 weeks. In protected mice, the inflammatory parameters in lesions, the percentage of CD69+CD3+ splenocytes, and the circulating natural killer T cells were reduced. Conclusions—The present study, therefore, shows that the proatherogenic potential of T cells is crucial in the progression of fatty streaks to mature plaques and requires cell division.

[1]  M. Rudling,et al.  Lesion Development and Response to Immunization Reveal a Complex Role for CD4 in Atherosclerosis , 2005, Circulation research.

[2]  J. Arnal,et al.  Deleting TCRαβ+ or CD4+ T Lymphocytes Leads to Opposite Effects on Site-Specific Atherosclerosis in Female Apolipoprotein E-Deficient Mice , 2004 .

[3]  H. Ljunggren,et al.  CD1d-dependent activation of NKT cells aggravates atherosclerosis. , 2004, The Journal of experimental medicine.

[4]  P. Gourdy,et al.  Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice. , 2003, Blood.

[5]  D. Klatzmann,et al.  Turning immunological memory into amnesia by depletion of dividing T cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  R. Flavell,et al.  Disruption of TGF-β signaling in T cells accelerates atherosclerosis , 2003 .

[7]  A. Tedgui,et al.  Induction of a Regulatory T Cell Type 1 Response Reduces the Development of Atherosclerosis in Apolipoprotein E–Knockout Mice , 2003, Circulation.

[8]  J. Witztum,et al.  Innate and acquired immunity in atherogenesis , 2002, Nature Medicine.

[9]  M. Linton,et al.  B-Lymphocyte Deficiency Increases Atherosclerosis in LDL Receptor–Null Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[10]  G. Hansson,et al.  Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. , 2002, The Journal of clinical investigation.

[11]  G. Hansson,et al.  In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. , 2001, Circulation.

[12]  Xinghua Zhou,et al.  Apolipoprotein E modulates immune activation by acting on the antigen-presenting cell. , 2001, Immunology.

[13]  Xinghua Zhou,et al.  Transfer of CD4+ T Cells Aggravates Atherosclerosis in Immunodeficient Apolipoprotein E Knockout Mice , 2000, Circulation.

[14]  D. Klatzmann,et al.  Preservation of graft-versus-infection effects after suicide gene therapy for prevention of graft-versus-host disease. , 2000, Human gene therapy.

[15]  D. Klatzmann,et al.  T-Cell suicide gene therapy for organ transplantation: induction of long-lasting tolerance to allogeneic heart without generalized immunosuppression. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[16]  M. Kronenberg,et al.  Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers , 2000, The Journal of experimental medicine.

[17]  A. Maseri,et al.  Evidence for Antigen-Driven T-Cell Response in Unstable Angina , 2000, Circulation.

[18]  D. Klatzmann,et al.  Prolonged allograft survival through conditional and specific ablation of alloreactive T cells expressing a suicide gene. , 2000, Transplantation.

[19]  G. Hansson,et al.  Molecular Medicine © 2000 The Picower Institute Press Induction of Neonatal Tolerance to Oxidized Lipoprotein Reduces Atherosclerosis In ApoE Knockout Mice , 2000 .

[20]  G. Hansson,et al.  Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. , 1999, Atherosclerosis.

[21]  Tzong-Shyuan Lee,et al.  The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[22]  S. Kaveri,et al.  Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice. , 1998, The Journal of clinical investigation.

[23]  A. Tall,et al.  IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. , 1997, The Journal of clinical investigation.

[24]  D. Klatzmann,et al.  Characterization of an intronless CD4 minigene expressed in mature CD4 and CD8 T cells, but not expressed in immature thymocytes. , 1996, Journal of immunology.

[25]  D. Klatzmann,et al.  A truncated herpes simplex virus thymidine kinase phosphorylates thymidine and nucleoside analogs and does not cause sterility in transgenic mice , 1995, Molecular and cellular biology.

[26]  S. Hedrick,et al.  A transcriptional silencer controls the developmental expression of the CD4 gene. , 1994, The EMBO journal.

[27]  D. Littman,et al.  A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development , 1994, Cell.

[28]  J. Arnal,et al.  Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice. , 2004, The American journal of pathology.

[29]  R. Flavell,et al.  Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. , 2003, The Journal of clinical investigation.

[30]  J. Michel,et al.  Interleukin-10 Deficiency Increases Atherosclerosis, Thrombosis, and Low-density Lipoproteins in Apolipoprotein E Knockout Mice , 2003, Molecular medicine.

[31]  G. Hansson,et al.  Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice. , 2000, Arteriosclerosis, thrombosis, and vascular biology.